julho 2025 | Hematology, Transfusion and Cell Therapy

A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW

Jiantuo Liu, Hongrui Li, Li Jiang, Xiangjun Chen, Yanli He

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.1

Acesso de texto completo

A NEW LOOK AT THE TREATMENT OF PATIENTS WITH ACUTE LEUKEMIA

MirEldar Babayev

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.2

Acesso de texto completo

CYTOGENETIC FEATURES OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH INTRACHROMOSOMAL AMPLIFICATION OF CHROMOSOME 21

Jiantuo Liu, Hongrui Li, Li Jiang, Ping Zhang, Shanlin Zheng, Xuekui Qiu, Haiqin Zhang

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.3

Acesso de texto completo

IMMUNOPHENOTYPIC CHARACTERISTICS AND TREATMENT OUTCOME OF T-ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS; AN IRAQI CENTER EXPERIENCE

Abdulsalam Al-Ani, Alaadin Sahham Naji, Luma Essa Hamodi, Alaa Fadhil Alwan

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.4

Acesso de texto completo

DYNAMIC BALANCE EVALUATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA UNDERGOING CONSOLIDATION THERAPY

Fulya Ipek-Erdem, Sena Sonkaya, Arzu Genç, Şebnem Yılmaz

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.5

Acesso de texto completo

INVESTIGATION OF POSTURAL CONTROL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Fulya Ipek-Erdem, Sena Sonkaya, Arzu Genç, Şebnem Yılmaz

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.6

Acesso de texto completo

PROGNOSTIC VALUE OF CD56 EXPRESSION IN CHILDREN WITH ACUTE MYELOID LEUKEMIA

Reyhan Aliyeva, Azer Kerimov, Naila Iasmayil, Gunel Aliyeva

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.7

Acesso de texto completo

LOW DOSE CYTARABINE PLUS SORAFENIB IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA

Tural Mahmudov

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.8

Acesso de texto completo

OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER EXPERIENCE

Yakup Unsal, Muhammed Murati, Guler Delibalta, Serdar Bedii Omay

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.9

Acesso de texto completo

EXPERIENCE WITH TOTALLY IMPLANTABLE VENOUS ACCESS PORTS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

Erkan Bilgin, Ahmet Bayrak

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.10

Acesso de texto completo

VALIDATION OF LONG-TERM HANDLING AND STORAGE CONDITIONS FOR HEMATOPOIETIC STEM CELL PRODUCTS FOR AUTOLOGOUS TRANSPLANTS

Ahmed Al Bahrani

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.11

Acesso de texto completo

CLINICO-BIOLOGICAL PROFILE AND MANAGEMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Vasile Musteata, Vasile Cepraga, Larisa Musteata

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.12

Acesso de texto completo

UNEXPECTED SPONTANEOUS REGRESSION IN CLL AFTER LETROZOLE TREATMENT: COINCIDENCE OR CONNECTION?

Ennur Ramadan, Mesut Seker, Guven Cetin

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.13

Acesso de texto completo

ANALYSIS OF RESPONSE TO FIRST-LINE THERAPY WITH IMATINIB IN AZERBAIJANI CML PATIENTS

Aypara Hasanova, Chingiz Asadov, Aytan Shirinova, Gunay Aliyeva, Zohra Alimirzoyeva

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.14

Acesso de texto completo

OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA IN OLDER ADULTS TREATED IN RESOURCE-CONSTRAINED SETTINGS

Natasha Ali, Raheel Iftikhar, Zeeshan Khan, Usman Ahmed, Humera Mahmood, Zeba Aziz

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.15

Acesso de texto completo

METHOTREXATE-ASSOCIATED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: TWO CASE REPORTS

Yakup Unsal, Muhammed Murati, Guler Delibalta, Serdar Bedii Omay, Vildan Yazici, Nedim Polat

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.16

Acesso de texto completo

RITUXIMAB WITH INVOLVED FIELD IRRADIATION FOR EARLY-STAGE DIFFUSE LARGE CELL LYMPHOMA

Vera Kovalskaya, Natalya Falaleeva, Stanislav Shklyaev, Andrey Chelmakov, Ludmila Grivtsova, Marwa Abdelgawad, Ahmed Mubarek

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.17

Acesso de texto completo

CASES OF PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA TREATED WITH SYSTEMIC OR LOCAL THERAPY

Müzeyyen Aslı Ergözoplu, Berksoy Şahin, Ertuğrul Bayram, Esra Gökçe

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.18

Acesso de texto completo

CLINICAL PRESENTATION AND OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME INTRODUCTION

Jehanzeb Ur Rehman

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.19

Acesso de texto completo

A CASE OF FAMILIAL PORFIRIA

Laman Hamidova, Oktay Abdullayev, Zari Balaşova, Farid Mammadov

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.20

Acesso de texto completo

CHIC2 DELETION-ASSOCIATED HYPEREOSINOPHILIA AND SUBSEQUENT JAK2 V617F POSITIVE THROMBOCYTOSIS

Mürüvvet Seda AYDIN, Emel Isleyen, Funda Ceran, Simten Dagdas, Gulsum Ozet

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.21

Acesso de texto completo

LYSOZYME-INDUCED NEPHROPATHY IN CMML: A RARE BUT SIGNIFICANT COMPLICATION REQUIRING EARLY RECOGNITION AND INTERVENTION

Alfadil Haroon, Mohamed Kindawi, Ahmed S Alotaibi, Ali Debsan Alahmari, Hazzaa Alzahrani, Mansour Alfayez, syed Osman Ahmed

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.22

Acesso de texto completo

LANDSCAPE OF SOMATIC MUTATIONS OF MYELOPROLIFERATIVE NEOPLASMS IN PAKISTANI PATIENTS

Mehreen Ali Khan

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.23

Acesso de texto completo

A CASE OF THROMBOCYTOSIS AND HEMOTHORAX IN A PATIENT WITH ITP FOLLOWING ROMIPLOSTIM USE

Ali Turunç, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.24

Acesso de texto completo

IMPACT OF LENALIDOMIDE MAINTENANCE DOSAGE ON SURVIVAL OUTCOMES IN MULTIPLE MYELOMA

Zeynep Kürüm, Ayfer Gedük

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.25

Acesso de texto completo

ASSESSMENT OF INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TEST IN A PATIENT WITH MULTIPLE MYELOMA: EXPERIENCE OF OUR MEDICAL GENETICS DEPARTMENT

Fatma Turki, Imen Rezgui, Faten Kallel, Moez Mdhaffer, Hassen Kamoun, Rim Frikha

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.26

Acesso de texto completo

TREATMENT MANAGEMENT IN MULTIPLE MYELOMA WITH RENAL DISORDER

Meryem Sener

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.27

Acesso de texto completo

THE SUCCESS LIES ON CLINICAL SUSPECT: THE SYNCHRONOUS CANCERS PRESENTING AS PULMONARY AND VERTEBRAL MASS LESIONS

Ulviyya Hasanzade, Metban Mastanzade, Sevgi Kalayoğlu Beşışık

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.28

Acesso de texto completo

ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSED FOUR YEARS AFTER HSCT IN A BETA THALASSEMIA PATIENT: A CLINICAL CASE

Samira Hasanova, Huseyn Kerimov, Avesta Allahverdiyeva, Azer Kerimov, Nargiz Aliyeva, Seher İsmayilova

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.29

Acesso de texto completo

INVESTIGATION OF THE RELATIONSHIP BETWEEN COMPASSION AND BURNOUT AMONG HEMATOLOGIST AND ONCOLOGIST

Nisa Aliş, Aze Buyruk, Birol Güvenç, Berksoy Şahin, Naciye Nur Tozluklu

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.30

Acesso de texto completo

A RARE CASE OF DIFFUSE LARGE B-CELL LYMPHOMA PRESENTING WITH CHRONIC GASTROINTESTINAL SYMPTOMS: A DIAGNOSTIC CHALLENGE

Bulut Sat, Burak Demir, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.31

Acesso de texto completo

ACUTE MYELOID LEUKEMIA PRESENTING AS ISOLATED MYELOID SARCOMA: A CASE REPORT

Elif Canpolat Hırfanoğlu, Ali Turunç, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.32

Acesso de texto completo

COLD AGGLUTININ DISEASE IN A PATIENT WITH WALDENSTRÖM’S MACROGLOBULINEMIA: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE

Ceren Kısa, Feride Aslanca, Melisa Ural, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.33

Acesso de texto completo

REVERSAL OF ACCELERATED PHASE CML WITH HIGH BLAST COUNT FOLLOWING 5+2 CHEMOTHERAPY AND DASATINIB: A CASE REPORT

Büşra Akdoğan, Ali Turunç, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.34

Acesso de texto completo

THERAPEUTIC APHERESIS FOR EPIDERMOLYSIS BULLOSA AND SECONDARY THROMBOCYTOSIS IN NORWEGIAN SCABIES: A CASE REPORT

Mine Ezgi Payaslı, Gökhan Demirci, Zeliha Yıldız Kandemir, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.35

Acesso de texto completo

TRANSFORMATION OF FOLLICULAR LYMPHOMA INTO DIFFUSE LARGE B-CELL LYMPHOMA AFTER A DECADE OF REMISSION: A CASE REPORT

Elif Canpolat Hırfanoğlu, Müjgan Çözeli, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103878.36

Acesso de texto completo

RISK OF DEVELOPING ONCOHEMATOLOGICAL DISEASES IN INDIVIDUALS INFECTED WITH HEPATITIS C AND B VIRUS

Gunel Alıyeva, Aytan Shirinova

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.1

Acesso de texto completo

LONG-TERM AND LATE EFFECTS OF CHEMOTHERAPY IN CHILDHOOD ACLEUKEMIA AND THEIR MANAGEMENT SINGLE INSTITUTION OBSERVATIONUTE LYMPHOBLASTIC

Konul Baghirova

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.2

Acesso de texto completo

REAL WORLD OUTCOMES OF HYPOMETHYLATING AGENTS AND VENETOCLAX COMBINATION THERAPY IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME- SINGLE CENTER EXPERIENCE FROM A RESOURCE LIMITED COUNTRY

Maryam Khan

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.3

Acesso de texto completo

THE ROAD NOT-TAKEN: EXPLORING NON-TRANSPLANT OPTIONS IN DE NOVO PHILADELPHIA - POSITIVE ACUTE MYELOID LEUKEMIA

Mohamed Sharif, Mansour Alfayez

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.4

Acesso de texto completo

CORRELATION OF СD10+ B-LYMPHOCYTES AND PLASMA CELLS WITH OUTCOME IN BREAST CANCER

Svetlana Chulkova

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.5

Acesso de texto completo

NEURON SPECIFIC ENOLASE POSITIVE OVARIAN INTERMEDIATE GRADE SERTOLI LEYDIG CELL TUMOR: A RARE CASE REPORT

Şule Çalişkan Kamiş, Elife Aşut, Begül Yağci

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.6

Acesso de texto completo

POLYRADICULOPATHY FOLLOWING CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES, DIAGNOSTIC CHALLENGES: A REPORT OF 3 CASES

Alfadil Haroon, Nawaf Aldawsari, Naeem Chaudhri, Ali Alahmari, Mahmoud Aljurf, Syed O Ahmed, Abdulwahab Albabtain

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.7

Acesso de texto completo

PRIMARY ADRENAL AND FEMALE GENITAL EXTRANODAL LYMPHOMAS

Müzeyyen Aslı Ergözoğlu, Berksoy Şahin, Tuğba Toyran, Nisa Aliş

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.8

Acesso de texto completo

EFFICACY OF ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS WITH ANEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Lokman Hekim Tanriverdi, Ayşe Uysal, Arzu Akyay, Yurday Öncül, Ahmet Sarici

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.9

Acesso de texto completo

Genetic profile of primary myelofibrosis patients in Azerbaijan

Elmir Guluyev, Madad Abbasov, Gulnar Garayeva, Azer Kerimov

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.10

Acesso de texto completo

TREATMENT OF BLAST PHASE MYELOPROLIFERATIVE NEOPLASM WITH THE COMBINATION OF AZACITIDINE, VENETOCLAX AND RUXOLITINIB

Fidan Khalilova, Azer Kerimov, Gulnar Kerimova

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.11

Acesso de texto completo

PROGNOSTIC IMPLICATIONS OF HIGH-RISK GENETIC MUTATIONS IN MULTIPLE MYELOMA PATIENTS UNDERGOING SECOND AUTOLOGOUS STEM CELL TRANSPLANT

Taner Tan, Ahmet Umur Topcu, Ümit Barbaros Üre, Emre Osmanbasoglu, Sinem Civriz Bozdağ, Olga Meltem Akay

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.12

Acesso de texto completo

TWO CASES OF PRIMARY AMYLOIDOSIS PRESENTING WITH VERTEBRAL AMYLOIDOMA

Ebru Kavak Yavuz, Vehbi Demircan, Abdullah Karakus, Orhan Ayyildiz

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.13

Acesso de texto completo

PROGRESSION OF POLYCYTHEMIA VERA TO ACUTE MYELOID LEUKEMIA FOLLOWING LONG-TERM HYDROXYUREA THERAPY: A CASE STUDY

Bengisu Ece Duman, Melis Selin Kadıoğlu, Halil İbrahim Yüksel, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.14

Acesso de texto completo

T-CELL LYMPHOMA DIAGNOSIS AND TREATMENT IN KOSOVO, A CROSS SECTIONAL STUDY

Adriatik Berisha

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.15

Acesso de texto completo

CHARACTERISTICS OF HEMATOLOGICAL MANIFESTATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: SINGLE CENTER EXPERIENCE

Gül Sandal Uzun

Hematol Transfus Cell Ther. 2025;47 Supl 2:103915.16

Acesso de texto completo